Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

  title={Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?},
  author={Rita Ko{\vc}{\'a}rov{\'a} and Jiř{\'i} Hor{\'a}{\vc}ek and Robin Lester Carhart-Harris},
  journal={Frontiers in Psychiatry},
Addressing global mental health is a major 21st-century challenge. Current treatments have recognized limitations; in this context, new ones that are prophylactic and effective across diagnostic boundaries would represent a major advance. The view that there exists a core of transdiagnostic overlap between psychiatric disorders has re-emerged in recent years, and evidence that psychedelic therapy holds promise for a range of psychiatric disorders supports the position that it may be… 

Figures and Tables from this paper

Psychedelic‐inspired approaches for treating neurodegenerative disorders

Evidence suggests that psychedelics and related compounds could prove useful for treating the behavioral and psychological symptoms of dementia (BPSD), and the robust effects of these compounds on structural and functional neuroplasticity and inflammation clearly warrant further investigation.

Psychedelic medicines for mood disorders: current evidence and clinical considerations

Purpose of review Despite advances in treatment modalities for mood disorders over recent decades, further therapeutic options are still required. Increased research is occurring, with the pursuit of

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

It is suggested that psychedelics can have a broad, robust and sustained positive impact on mental well-being in those that have a prior intention to use a psychedelic compound.

Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis.

The extremes of human experiences, such as those occasioned by classic psychedelics and psychosis, provide a rich contrast for understanding how components of these experiences impact well-being. In

Global Adversities, the Media, and Mental Health

Global communities are currently confronted with a number of complex problems and threats, the reality of which is amplified by the media. These environmental and socio-political stressors have been

A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review

Preliminary results from randomized controlled studies as well as identified molecular, cellular, and circuit targets of select psychedelics (e.g., psilocybin) suggest that their effects are

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world

Rationale A general feeling of disconnection has been associated with mental and emotional suffering. Improvements to a sense of connectedness to self, others and the wider world have been reported

N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine

Assessment of potential ayahuasca and N,N-dimethyltryptamine (DMT) integration with contemporary healthcare seeks to provide a summary of selected literature regarding the mechanisms of action of DMT andAyahuasca; and assess to what extent the state of research can explain reports of unusual phenomenology.



Psychedelics and the essential importance of context

This article highlights the pharmacological mechanisms of classic psychedelics that it is believed render their effects exceptionally sensitive to context, and develops an evidence base for long-held assumptions about the critical importance of context in relation to psychedelic use that can help minimise harms and maximise potential benefits.

How do psychedelics work?

It is proposed that psychedelics initiate a cascade of neurobiological changes that manifest at multiple scales and ultimately culminate in the relaxation of high-level beliefs and the purpose of psychedelic therapy is to harness the opportunity afforded by this belief-relaxation to achieve a healthy revision of pathological beliefs.

Serotonin, psychedelics and psychiatry

  • R. Carhart-Harris
  • Medicine, Psychology
    World psychiatry : official journal of the World Psychiatric Association
  • 2018
A global approach to healthy pregnancy and psychosis will depend upon the expansion of research to diverse lowand middle-income country settings, where maternal exposures and conditions affecting pregnancy are different, and access to prenatal care is more limited.

Psychedelics as Medicines: An Emerging New Paradigm

It is proposed that psychedelics exert therapeutic effects for psychiatric disorders by acutely destabilizing local brain network hubs and global network connectivity via amplification of neuronal avalanches, providing the occasion for brain network “resetting” after the acute effects have resolved.

Psychedelic treatment of functional neurological disorder: a systematic review

A systematically reviewed studies involving the use of psychedelics in FND, finding that 69% of patients treated were found to have made at least some recovery on heterogeneous and subjective clinician-rated criteria.

Ayahuasca as a Candidate Therapy for PTSD

Posttraumatic stress disorder (PTSD) is a syndrome that affects a substantial portion of both the civilian and military populations, and is often underdiagnosed due to complications with delayed

Pivotal mental states

It is argued that pivotal mental states serve an important evolutionary function, that is, to aid psychological transformation when actual or perceived environmental pressures demand this, and that serotonergic psychedelics hijack a system that has evolved to mediate rapid and deep learning when its need is sensed.

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation

Psychedelic therapy shows promise as a novel intervention for a wide range of mental health concerns but its therapeutic action is incompletely understood. In line with acceptance and commitment